Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...
Obstructive sleep apnea (OSA) is a common sleep disorder that occurs when the muscles in the throat relax too much during ...